Home    中文  
 
  • Search
  • lucene Search
  • Citation
  • Fig/Tab
  • Adv Search
Just Accepted  |  Current Issue  |  Archive  |  Featured Articles  |  Most Read  |  Most Download  |  Most Cited

Chinese Journal of Clinicians(Electronic Edition) ›› 2024, Vol. 18 ›› Issue (05): 496-499. doi: 10.3877/cma.j.issn.1674-0785.2024.05.009

• Review • Previous Articles    

Application of targeted contrast-enhanced ultrasound in treatment of atherosclerosis

Shaomin Wen1, Yaxi Wang1, Yilu Shi1, Shasha Duan1, Shurong Yun1, Xiaoshan Zhang1,()   

  1. 1. Department of Ultrasound, the Affiliated Hospital of Inner Mongolia Medical University, Hohhot 0100050, China
  • Received:2024-02-06 Online:2024-05-15 Published:2024-08-23
  • Contact: Xiaoshan Zhang

Abstract:

Atherosclerosis is a chronic progressive disease whose pathogenesis is complex and not yet fully understood. Atherosclerosis mainly invades large and medium-sized arteries such as the aorta, coronary artery, cerebral artery, and renal artery, and is the most common pathological basis for coronary artery disease, cerebrovascular disease, and peripheral artery disease. When plaques rupture and block major arteries throughout the body, it can lead to serious acute complications. The treatment of atherosclerosis mainly includes the control of risk factors, drug therapy, and surgery, but the therapeutic effects are not very satisfactory. In recent years, targeted contrast-enhanced ultrasound (CEUS) has shown promise in the precise treatment of atherosclerosis because of its advantages of non-invasiveness, accuracy, and real-time feedback. This article reviews the progress in the aplication of contrast-enhanced ultrasound in the treatment of atherosclerosis.

Key words: Ultrasound molecular imaging, Ultrasound contrast agent, Atherosclerosis, Low density lipoprotein, Therapy

京ICP 备07035254号-20
Copyright © Chinese Journal of Clinicians(Electronic Edition), All Rights Reserved.
Tel: 010-57830845 E-mail: zhlcyszz@cma.org.cn
Powered by Beijing Magtech Co. Ltd